Literature DB >> 27908289

Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.

Etienne Becht1,2,3,4, Nicolas A Giraldo1,2,3, Laetitia Lacroix1,2,3, Bénédicte Buttard1,2,3, Nabila Elarouci4, Florent Petitprez1,2,3,4, Janick Selves5,6, Pierre Laurent-Puig7, Catherine Sautès-Fridman1,2,3, Wolf H Fridman1,2,3, Aurélien de Reyniès8.   

Abstract

Entities:  

Year:  2016        PMID: 27908289      PMCID: PMC5134277          DOI: 10.1186/s13059-016-1113-y

Source DB:  PubMed          Journal:  Genome Biol        ISSN: 1474-7596            Impact factor:   13.583


× No keyword cloud information.

Erratum

After the publication of this work [1] it was noticed that the legend of Fig. 1a was incorrect. The correct legend should read: Flowchart of MCP-counter’s development and validation. It was also noted that in Fig. 2c the name of the last two genes was partially removed. The horizontal lines that were delineating the specificity of the displayed genes are missing. The corrected Fig. 2c is noted below.
Fig. 2

Identification and qualitative validation of transcriptomic markers. a The MCP discovery series. pDC plasmacytoid dendritic cell, PBMC peripheral blood mononuclear cell. b Quartiles of MCP-counter scores on positive and control samples in the discovery and validation microenvironment series. Gray indicates missing values. c Representative transcriptomic markers and their corresponding expression patterns in the MCP discovery series

Identification and qualitative validation of transcriptomic markers. a The MCP discovery series. pDC plasmacytoid dendritic cell, PBMC peripheral blood mononuclear cell. b Quartiles of MCP-counter scores on positive and control samples in the discovery and validation microenvironment series. Gray indicates missing values. c Representative transcriptomic markers and their corresponding expression patterns in the MCP discovery series The equal contributors symbol was missing for authors Aurélien de Reyniès and Wolf H. Fridman. This has now been corrected. In the PDF version of the article, equation 5 in the section ‘Correlation profiles of TM in microenvironment and tumor datasets’ is incorrect. Please see the correct equation below: The publisher apologises for these errors.
  1 in total

1.  Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.

Authors:  Etienne Becht; Nicolas A Giraldo; Laetitia Lacroix; Bénédicte Buttard; Nabila Elarouci; Florent Petitprez; Janick Selves; Pierre Laurent-Puig; Catherine Sautès-Fridman; Wolf H Fridman; Aurélien de Reyniès
Journal:  Genome Biol       Date:  2016-10-20       Impact factor: 13.583

  1 in total
  28 in total

1.  AURKA is a prognostic potential therapeutic target in skin cutaneous melanoma modulating the tumor microenvironment, apoptosis, and hypoxia.

Authors:  ShengYong Long; Xuan Fen Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-23       Impact factor: 4.322

2.  Transcriptome Analysis Reveals the Immune Infiltration Profiles in Cervical Cancer and Identifies KRT23 as an Immunotherapeutic Target.

Authors:  Xia Li; Yan Cheng; Yanmei Cheng; Huirong Shi
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

3.  Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.

Authors:  Nan Li; Kai Yu; Zhong Lin; Dingyuan Zeng
Journal:  Exp Biol Med (Maywood)       Date:  2021-10-21

4.  A pyroptosis-related prognosis model to predict survival in colorectal cancer patients.

Authors:  Meiyan Chen; Jingyi Zhang; Xiaoyan Lin; Xiaosan Zhu; Tao Xie
Journal:  Int J Clin Exp Pathol       Date:  2022-04-15

5.  Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.

Authors:  Karsten Krug; Eric J Jaehnig; Shankha Satpathy; Lili Blumenberg; Alla Karpova; Meenakshi Anurag; George Miles; Philipp Mertins; Yifat Geffen; Lauren C Tang; David I Heiman; Song Cao; Yosef E Maruvka; Jonathan T Lei; Chen Huang; Ramani B Kothadia; Antonio Colaprico; Chet Birger; Jarey Wang; Yongchao Dou; Bo Wen; Zhiao Shi; Yuxing Liao; Maciej Wiznerowicz; Matthew A Wyczalkowski; Xi Steven Chen; Jacob J Kennedy; Amanda G Paulovich; Mathangi Thiagarajan; Christopher R Kinsinger; Tara Hiltke; Emily S Boja; Mehdi Mesri; Ana I Robles; Henry Rodriguez; Thomas F Westbrook; Li Ding; Gad Getz; Karl R Clauser; David Fenyö; Kelly V Ruggles; Bing Zhang; D R Mani; Steven A Carr; Matthew J Ellis; Michael A Gillette
Journal:  Cell       Date:  2020-11-18       Impact factor: 41.582

6.  The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer.

Authors:  J Fay; S Toomey; A J Eustace; S F Madden; D M Collins; E W Kay; K M Sheehan; S Furney; B Moran; A Fagan; P G Morris; A Teiserskiene; A D Hill; L Grogan; J M Walshe; O Breathnach; C Power; D Duke; K Egan; W M Gallagher; N O'Donovan; J Crown; B T Hennessy
Journal:  Breast Cancer Res Treat       Date:  2021-05-13       Impact factor: 4.872

7.  Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors.

Authors:  Zhang-Wei Hu; Lin Chen; Ren-Qiang Ma; Fan-Qin Wei; Yi-Hui Wen; Xue-Lan Zeng; Wei Sun; Wei-Ping Wen
Journal:  Aging (Albany NY)       Date:  2021-04-16       Impact factor: 5.682

Review 8.  Single-Cell mRNA Sequencing in Cancer Research: Integrating the Genomic Fingerprint.

Authors:  Sören Müller; Aaron Diaz
Journal:  Front Genet       Date:  2017-05-31       Impact factor: 4.599

Review 9.  Microenvironmental Heterogeneity in Brain Malignancies.

Authors:  Lucas J M Perus; Logan A Walsh
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

10.  The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis.

Authors:  YiHeng Du; WenHao Miao; Xiang Jiang; Jin Cao; Bo Wang; Yi Wang; Jiang Yu; XiZhi Wang; HaiTao Liu
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.